Covid19 Clinical Trial
Official title:
Minnesota COVID-19 Testing Project
Verified date | October 2022 |
Source | Harvard University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, which is not random across the population and thus could lead to nonresponse bias. To do so, investigators are deploying flyers through 10 Twin City area food shelves and potentially through public housing units with information on how to answer an online questionnaire.
Status | Completed |
Enrollment | 561 |
Est. completion date | August 31, 2022 |
Est. primary completion date | August 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All participants who are aged 18 or above and speak English or Spanish Exclusion Criteria: - Children, those who do not identify as above or adults who identify as above but do not agree to participate in survey during the consent stage. |
Country | Name | City | State |
---|---|---|---|
United States | Volunteers Enlisted to Assist People | Bloomington | Minnesota |
United States | Southern Anoka Community Assistance | Columbia Heights | Minnesota |
United States | People Reaching Out to People Food Shelf | Eden Prairie | Minnesota |
United States | Fridley Covenant Church | Fridley | Minnesota |
United States | Calvary Lutheran Church Food Shelf | Minneapolis | Minnesota |
United States | Community Emergency Assistance Programs | Minneapolis | Minnesota |
United States | NorthPoint Health and Wellness | Minneapolis | Minnesota |
United States | Intercongregation Communities Association | Minnetonka | Minnesota |
United States | Valley Outreach | Stillwater | Minnesota |
United States | White Bear Area Foodshelf | White Bear Lake | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Harvard University | Abdul Latif Jameel Poverty Action Lab, Government of Minnesota Office of Management and Budget |
United States,
Griffin, DH. Measuring survey nonresponse by race and ethnicity. In Proceedings of the Annual Meetings of the American Statistical Association. 2002; 11-15.
Maitland A, Lin A, Cantor D, Jones M, Moser RP, Hesse BW, Davis T, Blake KD. A Nonresponse Bias Analysis of the Health Information National Trends Survey (HINTS). J Health Commun. 2017 Jul;22(7):545-553. doi: 10.1080/10810730.2017.1324539. Epub 2017 May 30. — View Citation
Meyer, Bruce D., Wallace KC Mok, and James X. Sullivan. Household surveys in crisis. Journal of Economic Perspectives. 2015; 29(4): 199-226.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effect of monetary incentives in increasing unit response 1 | Number of participants who received a flyer that mentions a $20 incentive and completed the survey | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Effect of monetary incentives in increasing unit response 2 | Number of participants who received a flyer that mentions a $10 incentive and completed the survey. | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Effect of a government frame in reducing unit response 1 | Number of participants who received a flyer that mentions a government frame and completed the survey | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Effect of a government frame in reducing unit response 2 | Number of participants who received a flyer that mentions a research frame and completed the survey. | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Interactions between monetary incentives and a government frame 1 | Number of participants who received a flyer that mentions a government frame and $20 incentive and completed the survey | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Interactions between monetary incentives and a government frame 2 | Number of participants who received a flyer that mentions a government frame and $10 incentive and completed the survey | This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes. | |
Primary | Interactions between monetary incentives and a government frame 3 | Number of participants who received a flyer that mentions a researcher frame and $20 incentive and completed the survey | This outcome will be assessed during the 20-minute Baseline Survey. | |
Primary | Interactions between monetary incentives and a government frame 4 | Number of participants who received a flyer that mentions a researcher frame and $10 incentive and completed the survey | This outcome will be assessed during the 20-minute Baseline Survey. | |
Primary | Demographic characteristics of participants assigned into each treatment arm | Demographic characteristics (e.g. sex, education level, income level, race/ethnicity) of participants who are assigned to each treatment arm and completed the survey. | This outcome will be assessed during the 20-minute Baseline Survey. | |
Primary | Effect of various messaging frames in increasing item non-response | Number of survey participants who are randomly assigned to receive each messaging frame that: a) emphasizes the public health benefits of answering the survey questions (cost-benefit frame); b) emphasizes an individual's responsibility to their community (duty frame); c) emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups; or d) provides no messaging. | This outcome will be assessed during the 20-minute Baseline Survey. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |